Login

Saundra Pelletier, CEO, Evofem Biosciences 00:00:00

Share On Facebook Share On Twitter

CEO Saundra Pelletier empowers women through Evofem’s healthcare products and business model

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
$1.15 billion stake in its company to Sequoia and Paradigm in January 2022|Alfred Lin,Investor, Sequoia
00:10:00
Tom Lister of Permira on Strategic Sectors, Selling Strategy, and Investor Resilience | Tom Lister, Co-Managing Partner, Permira.
00:10:00
Forecasting the Future: A Decade of Change with Hamish Douglass and Andrew Clifford | Andrew Clifford , CEO , Platinum Asset Management.
00:10:00
Fortune Minerals CEO Robin Goad Showcases $145M Vertically Integrated Critical Minerals Project Supporting Energy Transition and National Security
00:10:00
$750 million fund focused on both direct investments and investments in other venture funds|Rick Smith,CO-FOUNDER & MANAGING DIRECTOR,Crosscut Ventures
00:10:00
Granite Creek Copper Expands Presence in Yukon with Acquisition, Eyes Future Growth
00:10:00
The Trailblazing US VC Investing in Latin American Fintech|Mike Packer,Partner,QED Investors
00:10:00
Innovation and Community Impact in Hospitality Real Estate
00:10:00
Targeting the Lost Generation: Bridging the Age Gap in Broadcasting | Karl Thedéen , CEO of Edgeware AB
00:10:00
Drew McKnight, co-founder of Fortress Investment Group, contributes to financial discussions on CNBC LLC, covering various topics including financial advisors and options.|Drew McKnight, co-founder of Fortress Investment Group
00:10:00
Thor Explorations: Advancing High-Grade Gold Projects in West Africa
00:10:00
CEO discusses expansion of cancer biomarker technology research program and future commercialization plans with University of York collaboration | Allan Syms,CEO, Cizzle Biotechnology Holdings PLC.

© 2017 - Neuhu+